María Muñoz-García

Dr. María Muñoz-García


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 December 2023 in Journal of Asthma
Verified
Journal Article
Open access
EMEva Martínez-Moragón
Eva Martínez-Moragón
IEIgnacio Antepara Ercoreca
Ignacio Antepara Ercoreca
MMMaría Muñoz-García
María Muñoz-García
OEon behalf of the PROs-SA group of experts
on behalf of the PROs-SA group of experts
FMFrancisco Casas Maldonado
Francisco Casas Maldonado
SSSilvia Sánchez-Cuellar
Silvia Sánchez-Cuellar
The study aimed to reach a consensus on the most relevant patient-reported outcomes (PROs), the corresponding measures (PROMs), and measurement frequency during severe asthma patient follow-up. Two Delphi rounds were conducted. The questionnaire was developed based on a systematic literature review, a focus group with patients, and a nominal group with experts. It assessed PROs' relevance and the appropriateness (A) and feasibility (F) of PROMs using a Likert scale (1=totally agree; 9=totally disagree). The consensus was established when ≥75% of participants agreed (1-3) or disagreed (7-9). Sixty-three professionals (25 hospital pharmacists, 14 allergists, 13 pulmonologists, and 11 nurses) and 5 patients answered the Delphi questionnaire. A consensus was reached on all PROs regarding their relevance. Experts agreed on the use of ACT (A:95.24%; F:95.24%), mini AQLQ (A:93.65; F:79.37%), mMRC dyspnea scale (A:85.71%; F:85.71%), TAI (A:92.06%; F:85.71%), MMAS (A:75.40%; F:82%), and the dispensing register (A:96.83%; F:92.06%). Also considered suitable were: SNOT-22 (A:90.48%; F:73.80%), PSQI (A:82.54; F:63.90%), HADS (A:82.54; F:64%), WPAI (A:77.78%; F:49.20%), TSQM-9 (A:79.37; F:70.50%) and knowledge of asthma questionnaire (A:77%; F:68.80%); however, their use in clinical practice was considered unfeasible. Panelists also agreed on the appropriateness of EQ-5D, which was finally included despite being considered unfeasible (A: 84.13%; F:67.20%) in clinical practice. Agreement was reached on using ACT, TAI, mMRC, and a dispensing register every three months; mini-AQLQ and MMAS every six months; and EQ-5D every twelve months. This consensus paves the way toward patient-centered care, promoting the development of strategies supporting routine assessment of PROs in severe asthma management.

3 February 2023 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
PDF file
MMMaría Muñoz-García
María Muñoz-García
HMHilario Martínez-Barros
Hilario Martínez-Barros
SSSilvia Sánchez-Cuéllar
Silvia Sánchez-Cuéllar
AMAna Morales-Tirado
Ana Morales-Tirado
ADAna De-Andrés-Martín
Ana De-Andrés-Martín
DGDavid Gonzalez-de-Olano
David Gonzalez-de-Olano
Severe asthma has an important impact on patients and healthcare resources. Recently, the new specific treatments have defined a new scenario in which person-focused care and specialist multidisciplinary teams are necessary. Our Severe Asthma Unit (SAU) started the ASfarMA project along with an external human-centered design company to understand patients’ vision of their illness, treatment, and healthcare experience, and to define the ideal SAU by performing a core group session, in-depth semistructured interviews and co-creation workshop. Herein, a series of tips classified as either ‘transformative solutions’ or ‘quick wins’, according to a value versus effort matrix are presented. Successful implementation of the proposed solutions will be valuable for patients and healthcare professionals, optimising patient care and resources. These findings can also be helpful to other SAUs or other humanisation projects involving complex, chronic and multidisciplinary pathologies.

1 November 2016
Verified
Journal Article
Closed access
MMMaría Muñoz-García
María Muñoz-García
ESEva Delgado Silveira
Eva Delgado Silveira
SÁSagrario Martín-Aragón Álvarez
Sagrario Martín-Aragón Álvarez
TVTeresa Bermejo Vicedo
Teresa Bermejo Vicedo
ACAlfonso J. Cruz-Jentoft
Alfonso J. Cruz-Jentoft